169 related articles for article (PubMed ID: 37418095)
1. Risk factors for mortality after hip fracture surgery in Japan using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Nishimura Y; Inagaki Y; Noda T; Nishioka Y; Myojin T; Ogawa M; Kido A; Imamura T; Tanaka Y
Arch Osteoporos; 2023 Jul; 18(1):91. PubMed ID: 37418095
[TBL] [Abstract][Full Text] [Related]
2. Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database.
Mori T; Komiyama J; Fujii T; Sanuki M; Kume K; Kato G; Mori Y; Ueshima H; Matsui H; Tamiya N; Sugiyama T
Arch Osteoporos; 2022 Apr; 17(1):61. PubMed ID: 35403938
[TBL] [Abstract][Full Text] [Related]
3. Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Nakatoh S; Fujimori K; Ishii S; Tamaki J; Okimoto N; Ogawa S; Iki M
Arch Osteoporos; 2021 Sep; 16(1):130. PubMed ID: 34510296
[TBL] [Abstract][Full Text] [Related]
4. Is Delayed Time to Surgery Associated with Increased Short-term Complications in Patients with Pathologic Hip Fractures?
Varady NH; Ameen BT; Chen AF
Clin Orthop Relat Res; 2020 Mar; 478(3):607-615. PubMed ID: 31702689
[TBL] [Abstract][Full Text] [Related]
5. Comparative Interrupted Time Series Analysis of Long-term Direct Medical Costs in Patients With Hip Fractures and a Matched Cohort: A Large-database Study.
Jang SY; Lee JW; Kim KJ; Kim HY; Choy WS; Cha Y
Clin Orthop Relat Res; 2022 May; 480(5):891-902. PubMed ID: 34807010
[TBL] [Abstract][Full Text] [Related]
6. Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.
Tamaki J; Fujimori K; Ikehara S; Kamiya K; Nakatoh S; Okimoto N; Ogawa S; Ishii S; Iki M;
Osteoporos Int; 2019 May; 30(5):975-983. PubMed ID: 30648192
[TBL] [Abstract][Full Text] [Related]
7. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Imano H; Ogawa S
Osteoporos Int; 2024 May; 35(5):805-818. PubMed ID: 38267664
[TBL] [Abstract][Full Text] [Related]
8. Association of pharmacotherapy with the second hip fracture incidence in women: A retrospective analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Nakatoh S; Fujimori K; Ishii S; Tamaki J; Okimoto N; Ogawa S; Iki M
Geriatr Gerontol Int; 2022 Nov; 22(11):930-937. PubMed ID: 36167466
[TBL] [Abstract][Full Text] [Related]
9. How Common-and How Serious- Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset.
Bovonratwet P; Bohl DD; Russo GS; Ondeck NT; Nam D; Della Valle CJ; Grauer JN
Clin Orthop Relat Res; 2018 Mar; 476(3):453-462. PubMed ID: 29443839
[TBL] [Abstract][Full Text] [Related]
10. Delayed initiation of anti-osteoporosis medications increases subsequent hip and vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Bone; 2022 Jul; 160():116396. PubMed ID: 35351673
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the risk factors of mortality in elderly patients with hip fracture using a combined database of medical and long-term care insurance claims data.
Takagi K; Matsugaki R; Fujimoto K; Mine Y; Muramatsu K; Fujino Y; Matsuda S
J Orthop Sci; 2023 May; 28(3):627-630. PubMed ID: 35123843
[TBL] [Abstract][Full Text] [Related]
12. Incidence of fractures among patients receiving medications for type 2 diabetes or chronic obstructive pulmonary disease and glucocorticoid users according to the National Claims Database in Japan.
Fujiwara S; Ishii S; Hamasaki T; Okimoto N
Arch Osteoporos; 2021 Jun; 16(1):106. PubMed ID: 34191131
[TBL] [Abstract][Full Text] [Related]
13. Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the national health insurance claims data.
Kang HY; Yang KH; Kim YN; Moon SH; Choi WJ; Kang DR; Park SE
BMC Public Health; 2010 May; 10():230. PubMed ID: 20438644
[TBL] [Abstract][Full Text] [Related]
14. Mortality associated with bone fractures in COPD patients.
Yamauchi Y; Yasunaga H; Sakamoto Y; Hasegawa W; Takeshima H; Urushiyama H; Jo T; Matsui H; Fushimi K; Nagase T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2335-2340. PubMed ID: 27703343
[TBL] [Abstract][Full Text] [Related]
15. A Tool to Estimate Risk of 30-day Mortality and Complications After Hip Fracture Surgery: Accurate Enough for Some but Not All Purposes? A Study From the ACS-NSQIP Database.
Harris AHS; Trickey AW; Eddington HS; Seib CD; Kamal RN; Kuo AC; Ding Q; Giori NJ
Clin Orthop Relat Res; 2022 Dec; 480(12):2335-2346. PubMed ID: 35901441
[TBL] [Abstract][Full Text] [Related]
16. Length of hospital stay after hip fracture surgery and 1-year mortality.
Yoo J; Lee JS; Kim S; Kim BS; Choi H; Song DY; Kim WB; Won CW
Osteoporos Int; 2019 Jan; 30(1):145-153. PubMed ID: 30361752
[TBL] [Abstract][Full Text] [Related]
17. Timing of surgery for hip fractures in the elderly: A retrospective cohort study.
Sasabuchi Y; Matsui H; Lefor AK; Fushimi K; Yasunaga H
Injury; 2018 Oct; 49(10):1848-1854. PubMed ID: 30097309
[TBL] [Abstract][Full Text] [Related]
18. Report on the Japanese Orthopaedic Association's 3-year project observing hip fractures at fixed-point hospitals.
Sakamoto K; Nakamura T; Hagino H; Endo N; Mori S; Muto Y; Harada A; Nakano T; Yamamoto S; Kushida K; Tomita K; Yoshimura M; Yamamoto H
J Orthop Sci; 2006 Mar; 11(2):127-34. PubMed ID: 16568383
[TBL] [Abstract][Full Text] [Related]
19. Association between time to surgery and 90-day mortality after hip fracture: A retrospective cohort study of 1734 cases.
Kawai M; Tanji A; Nishijima T; Tateyama K; Yoda Y; Iizuka A; Kamata Y; Urabe T
J Orthop Sci; 2018 Nov; 23(6):987-991. PubMed ID: 30119928
[TBL] [Abstract][Full Text] [Related]
20. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
